Literature DB >> 25669899

What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Jennifer Manning1, Dervla O'Malley.   

Abstract

Duchenne muscular dystrophy (DMD) is a fatal X-chromosome linked recessive disorder caused by the truncation or deletion of the dystrophin gene. The most widely used animal model of this disease is the dystrophin-deficient mdx mouse which was first discovered 30 years ago. Despite its extensive use in DMD research, no effective treatment has yet been developed for this devastating disease. This review explores what we have learned from this mouse model regarding the pathophysiology of DMD and asks if it has a future in providing a better more thorough understanding of this disease or if it will bring us any closer to improving the outlook for DMD patients.

Entities:  

Mesh:

Year:  2015        PMID: 25669899     DOI: 10.1007/s10974-015-9406-4

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  159 in total

1.  Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study.

Authors:  D Cros; P Harnden; J F Pellissier; G Serratrice
Journal:  J Neurol       Date:  1989-01       Impact factor: 4.849

2.  Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.

Authors:  E Araki; K Nakamura; K Nakao; S Kameya; O Kobayashi; I Nonaka; T Kobayashi; M Katsuki
Journal:  Biochem Biophys Res Commun       Date:  1997-09-18       Impact factor: 3.575

3.  Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles.

Authors:  R Gilbert; J Nalbantoglu; B J Petrof; S Ebihara; G H Guibinga; J M Tinsley; A Kamen; B Massie; K E Davies; G Karpati
Journal:  Hum Gene Ther       Date:  1999-05-20       Impact factor: 5.695

Review 4.  Cardiac assessment in duchenne and becker muscular dystrophies.

Authors:  Anitra Romfh; Elizabeth M McNally
Journal:  Curr Heart Fail Rep       Date:  2010-12

5.  Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.

Authors:  B L Bia; P J Cassidy; M E Young; J A Rafael; B Leighton; K E Davies; G K Radda; K Clarke
Journal:  J Mol Cell Cardiol       Date:  1999-10       Impact factor: 5.000

6.  Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy.

Authors:  Olivier M Dorchies; Stéphanie Wagner; Ophélie Vuadens; Katri Waldhauser; Timo M Buetler; Pavel Kucera; Urs T Ruegg
Journal:  Am J Physiol Cell Physiol       Date:  2006-02       Impact factor: 4.249

7.  Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.

Authors:  Hannah G Radley; Marilyn J Davies; Miranda D Grounds
Journal:  Neuromuscul Disord       Date:  2008-01-22       Impact factor: 4.296

8.  Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.

Authors:  Elise Mok; Guy Letellier; Jean-Marie Cuisset; André Denjean; Frédéric Gottrand; Corinne Alberti; Régis Hankard
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

9.  Diaphragmatic function in advanced Duchenne muscular dystrophy.

Authors:  Jennifer Beck; Jan Weinberg; Carl-Hugo Hamnegård; Jadranka Spahija; Jan Olofson; Gunnar Grimby; Christer Sinderby
Journal:  Neuromuscul Disord       Date:  2006-02-20       Impact factor: 4.296

10.  In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.

Authors:  Daniel J Stuckey; Carolyn A Carr; Patrizia Camelliti; Damian J Tyler; Kay E Davies; Kieran Clarke
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

View more
  35 in total

Review 1.  Gene Therapy for Heart Failure: New Perspectives.

Authors:  Khatia Gabisonia; Fabio A Recchia
Journal:  Curr Heart Fail Rep       Date:  2018-12

2.  Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.

Authors:  Eleanor C Hawkins; Amanda K Bettis; Joe N Kornegay
Journal:  Neuromuscul Disord       Date:  2020-09-20       Impact factor: 4.296

Review 3.  Overview of the Muscle Cytoskeleton.

Authors:  Christine A Henderson; Christopher G Gomez; Stefanie M Novak; Lei Mi-Mi; Carol C Gregorio
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

Review 4.  Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules.

Authors:  Mark G Rae; Dervla O'Malley
Journal:  J Neurophysiol       Date:  2016-07-06       Impact factor: 2.714

Review 5.  Hydrogen sulfide pathway and skeletal muscle: an introductory review.

Authors:  Valentina Vellecco; Chiara Armogida; Mariarosaria Bucci
Journal:  Br J Pharmacol       Date:  2018-06-15       Impact factor: 8.739

6.  Fast skeletal myofibers of mdx mouse, model of Duchenne muscular dystrophy, express connexin hemichannels that lead to apoptosis.

Authors:  Luis A Cea; Carlos Puebla; Bruno A Cisterna; Rosalba Escamilla; Aníbal A Vargas; Marina Frank; Paloma Martínez-Montero; Carmen Prior; Jesús Molano; Isabel Esteban-Rodríguez; Ignacio Pascual; Pía Gallano; Gustavo Lorenzo; Héctor Pian; Luis C Barrio; Klaus Willecke; Juan C Sáez
Journal:  Cell Mol Life Sci       Date:  2016-01-23       Impact factor: 9.261

7.  Galectin-3 and N-acetylglucosamine promote myogenesis and improve skeletal muscle function in the mdx model of Duchenne muscular dystrophy.

Authors:  Ann Rancourt; Sébastien S Dufresne; Guillaume St-Pierre; Julie-Christine Lévesque; Haruka Nakamura; Yodai Kikuchi; Masahiko S Satoh; Jérôme Frenette; Sachiko Sato
Journal:  FASEB J       Date:  2018-06-12       Impact factor: 5.191

8.  Chick embryonic cells as a source for generating in vitro model of muscle cell dystrophy.

Authors:  Verma Urja; Kashmira Khaire; Suresh Balakrishnan; Gowri Kumari Uggini
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-10-09       Impact factor: 2.416

9.  Persistent mdx diaphragm alterations are accompanied by increased expression and activity of calcium and muscle-specific proteins.

Authors:  Rhayanna B Gaglianone; Flavia Fonseca Bloise; Jussara Lagrota-Candido; Claudia Mermelstein; Thereza Quirico-Santos
Journal:  Histol Histopathol       Date:  2021-04-07       Impact factor: 2.303

10.  In Vivo Fiber Optic Raman Spectroscopy of Muscle in Preclinical Models of Amyotrophic Lateral Sclerosis and Duchenne Muscular Dystrophy.

Authors:  Maria Plesia; Oliver A Stevens; Gavin R Lloyd; Catherine A Kendall; Ian Coldicott; Aneurin J Kennerley; Gaynor Miller; Pamela J Shaw; Richard J Mead; John C C Day; James J P Alix
Journal:  ACS Chem Neurosci       Date:  2021-05-05       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.